Buffett da inizio anno...

locco68

Fiorentina
Registrato
28/2/04
Messaggi
11.688
Punti reazioni
1.172
Ha fatto _0,3% contro il -9 % dello S&P (con i nuovi acquisti)

What If You Bought Buffett’s Top Picks: Kraft Foods Inc., Burlington Northern Santa Fe Corp., Wells Fargo and Company, Carmax Inc. and GlaxoSmithKline?
March-18-2008



S&P 500 is down 9.3% year to date. How are the recent picks of Warren Buffett? What if you have bought these stocks after we report them? This is our study.

Warren Buffett’s stock holdings seem unhurt by the recent market downturn. With this study we would like to review the performances of his largest picks year to date, and compare it with the market average. Also we like to answer an interesting question: what if you bought these stocks on the day we report them? How well will you do?

Warren Buffett’s top four stocks picks last quarter were Kraft Foods Inc. (KFT), Burlington Northern Santa Fe Corp. (BNI), Wells Fargo and Company (WFC), and Carmax Inc. (KMX). Berkshire Hathaway also initiated holdings in GlaxoSmithKline plc (GSK). The performances of these stocks are show in table below.



WEB's Year to Date Performance

SYMBOL START (Jan. 2, 2008) END (Mar. 18, 2008) GAIN
KFT $32.55 $30.56 -6.1%
BNI $83.34 $92.98 13.96%
WFC $30.48 $31.54 3.5%
GSK $50.45 $42.32 -16.11%
KMX $19.88 $20.5 3.12%

AVERAGE: -0.3%, S&P: -9.3%
The average return of these five stocks is 0% year to date, which is 9% better than the 9.3% decline of S&P100. In less than 3 months, these stocks have outperformed the market average by 9%.

Since we are not aware of his last quarter stock picks until Feb. 15, we like to check the performances of these stocks after that. Since Feb. 15, these stocks have returned an average of 1.88%, which is better than the 1.4% decline of S&P500 by 3.2%. The details are shown in this table:



WEB's Feb. 15 to Date Performance

SYMBOL START (Feb. 15, 2008) END (Mar. 18, 2008) GAIN
KFT $30.29 $30.56 0.89%
BNI $88.92 $92.98 4.57%
WFC $29.42 $31.54 7.21%
GSK $44 $42.32 -3.82%
KMX $20.39 $20.5 0.54%

AVERAGE: 1.88%, S&P: -1.4%
Kraft Foods, Inc (KFT), Down 6.1% Year to Date
Kraft Foods, Inc (KFT) is Warren Buffett’s largest purchase during the past quarter. As of Dec. 31, 2007, Buffett owns more than 132 million shares of Kraft. He started to accumulate KFT since the first half of 2007, and delayed his reporting until February of 2008. The stock is down 6.1% year to date, better than S&P 500 by 3.2%.

The news that Warren Buffett purchases Kraft Foods has triggered a lot of discussions among our users. With an “elephant gun,” Warren Buffett does not have many elephants to hunt from. Kraft seems to fit his criteria of simple and good business.

Kraft Foods, Inc. engages in the manufacture and marketing of packaged foods and beverages worldwide. It has a market cap of $46.86 billion; its shares were traded at around $30.6 with a P/E ratio of 18.81 and P/S ratio of 1.23. The dividend yield of Kraft Foods Inc. stocks is 3.6%.

Kraft is widely owned among other Gurus. Richard Aster Jr bought 22,400 shares in the quarter that ended on 12/31/2007, which is 0.02% of the $3.4 billion portfolio of Meridian Fund. There are quite some insider buying activities too within Kraft Foods.

Burlington Northern Santa Fe Corporation (BNI), Up 13.96% Year to Date
Warren Buffett keeps buying BNI over the past year. He bought BNI at the prices between $75 to $85. As of Jan., Berkshire owns more than 63 million shares, representing more than 18% of total shares outstanding.

Buffett’s purchases of railroad companies surprised a lot of his followers initially. During the Berkshire annual meeting last year, Buffett said that railroad business would never be "sensational," yet its prospects had improve. Charlie Munger, Vice Chairman of Berkshire Hathaway, commented during the annual meeting of Wesco Financial (WSC), Buffett and he himself “used to not like them because they needed large amounts of capital, had tough unions, and stiff competition from the trucking business. The paradigm had shifted. Now the railroad industry has a competitive advantage by double-stacking freight. With all of the imports from China , the U.S. has a huge amount of freight being sent across the county.”

Wells Fargo & Company (WFC), Update 3.5% Year to Date
Wells Fargo & Company is a long term holding of Buffett. He praised the quality of the company many times in his interviews before. Wells Fargo seems unscratched by the financial crunch other banks are experiencing.

In his most recent shareholder letter, Buffett wrote: Some major financial institutions have, however, experienced staggering problems because they engaged in the “weakened lending practices” I described in last year’s letter. John Stumpf, CEO of Wells Fargo , aptly dissected the recent behavior of many lenders: 'It is interesting that the industry has invented new ways to lose money when the old ways seemed to work just fine.”

Wells Fargo Chairman Richard Kovacevich said that they will increase acquisitions this year, and the targets are likely to be larger than the banks bought recently. He also said “We are finding more assets at better values than we've seen in five years.”

Wells Fargo & Company has a market cap of $103.98 billion; its shares were traded at around $ 31.54 with a P/E ratio of 13.24 and P/S ratio of 2.75. The dividend yield of Wells Fargo & Company stocks is 4.4%.

Carmax Inc (KMX) and GlaxoSmithKline plc (GSK)
These two stocks have less than 1% of position in Berkshire ’s Portfolio. They may be from the equity holdings of Geico, which is managed by Lou Simpson. GlaxoSmithKline plc (GSK) recently hit 52-week low as health-care stocks are sold off on Wall Street.
 
Intanto Berkshire ha completato l'acquisizione del 60 % del gruppo Marmon per 4,5 miliardi di dollari aggiungendo alle svariate attività del gruppo la bellezza di 125 aziende indipendenti che operano in svariati settori industriali.
Ne avrà di strada da fare il buon Warren per andare a visitarle tutte...
 
Come si fa a copiare tutte le strategie di Buffet passo x passo?

Potresti anche copiare gli acquisti che effettua lui, magari con qualche mese di ritardo è probabile che faresti comunuqe meglio del
1) fai da te
2) del risparmio gestito e attivo
ma ormai devi tener conto che i suoi acquisti e il portafoglio sono adatti per una holding come la sua, meno per un singolo e piccolo investitore, ma il lato positivo viene invece dalle aziende operative che controlla, sono quelle i generatori di liquidità, e cosi, vista l'impossibilità di copiarlo, meglio prendere le sue azioni e far "lavorare" lui...
gioia23
 
è sempre interessante...
nel frattempo si è anche saputo che una delle due aziende tedesche che stava accumulando sembra sia Muenchner Rueck, di cui dovrebbe tenere circa il 0,5%, si attende conferma
gioia23



Why Did Buffett Buy Glaxo SmithKline and Kraft?

by: Dickie Paria posted on: April 10, 2008 | about stocks: BRK.A / BRK.B / GSK / K Font Size: PrintEmail There has been much discussion on the internet on why Buffett selected Glaxo SmithKline (GSK) and Kraft (KFT). As with many of Buffett's picks, there seems to be general confusion on whether Buffett made a "wise" selection or not and angst on whether investors should follow Buffett's GSK and KFT picks. I used Morningstar's Portfolio Manager tool to determine whether GSK and KFT were the 'best' companies among popular Drugs & Biotech and Food & Beverage Manufacturers respectively. I then used Morningstar's Fair Value Estimate to see if GSK and KFT were selling at a discount to fair value estimate.



I picked four metrics from the Portfolio Manager toolbox to determine whether GSK was the 'best' company among well known Drug & Biotech companies. The four metrics were three year revenue growth, three year earnings per share growth, three year equity per share growth and R&D/revenue (five year average percent). I took three year averages since Buffett tells us not to focus on yearly results. The R&D ratio was a five year average as Morningstar does not provide 3 year averages for that metric.



I used the first three metrics mentioned above to determine whether KFT was the 'best' company among well known Food & Beverage Manufacturers. The R&D ratio was dropped as Morningstar did not show R&D expenses for many of the companies.

The revenue growth metric was selected since Buffett looks for companies with favorable long term prospects. The earnings per share growth metric reflects how well the company converts sales to profits. The equity per share growth reflects how well the companies are increasing shareholder value. I've included the R&D to revenues metric since drug and biotech companies live and die by their success in bringing new products to market.

I selected seventeen well known Drug & Biotech companies to compare to GSK. They are: Gilead (GILD), Teva (TEVA), Schering-Plough (SGP), Wyeth (WYE), Sanofi-Aventis (SNY), Novartis (NVS), Novo Nordisk (NVO), AstraZeneca (AZN), Genetech (DNA), Alcon (ACL), Amgen (AMGN), Johnson & Johnson (JNJ), Eli Lilly (LLY), Abbott Laboratories (ABT), Merck (MRK), Pfizer (PFE) and Bristol Myer (BMY). For Food & Beverage Manufacturers, I selected thirty five companies to compare to KFT. They are: Constellation Brands (STZ.B), Anheuser Busch (BUD), Companhia de Bebidas das Americas (ABV), BG, CU, Constellation Brands (STZ), Wolverine Worldwide (WWW), Pepsi (PEP), Hansen Natural (HANS), Wrigley (WWY), Unilever (UL), Coca-Cola (KO), Smucker (SJM), Pepsi Bottling Group (PBG), General Mills (GIS), Tyson Foods (TSN), Coca-Cola Enterprise (CCE), Unilever N.V (UN), SABMiller (SBMRY), Coca-Cola FEMSA (KOF), Campbell (CPB), Sara Lee (SLE), ConAgra (CAG), PepsiAmericas (PAS), Diageo (DEO), Kellogg (K), Hershey (HSY), McCormick (MKC), Brown-Forman (BF.B), Cadbury Schweppes (CSG), Nestle (NSRGY), Heinz (HNZ), Molson Coors (TAP.A), Kirin Holdings (KNBWY) and Molson Coors (TAP).

Each of the metrics was sorted from lowest growth to highest growth and numbered in sequence. That is - the company with the lowest earnings per share growth figure was numbered '1' and the next lowest was numbered '2' and so on. The numbers for each metric for each company was then summed. The company with the highest total number would, theoretically, have the best combination of revenue, earnings per share, equity and, in the case of Drugs & Biotech, R&D to revenue growth.

GSK received the highest number (65) among the Drug & Biotech companies while KFT received the highest number (108) among the Food & Beverage Manufacturers. To those who are curious about Buffet's other two drug company choices: Sanofi Aventis came in at number six behind Gilead Sciences, Teva Pharm, Schering-Plough and Wyeth (in that order) while Johnson & Johnson came in at number thirteen.

According to Morningstar's Fair Value Estimate, GSK's and KFT's intrinsic value is $57 and $40 respectively and the stocks are trading well below the intrinsic values.

Disclosure: none
 
Lascia perdere ..comprati azioni Berkshire e lasciale li a maturare.

Mha si costano circa 131000 dollari ad azione... ne prenderei 1000 overnight leva 20 cosa ne dite faccio un buon affare?

p.s. ovviamente sto scherzando...
 
Mha si costano circa 131000 dollari ad azione... ne prenderei 1000 overnight leva 20 cosa ne dite faccio un buon affare?

p.s. ovviamente sto scherzando...

Attenzione che esiste anche la Berkshire B che costa circa 4300 dollari che al cambio attuale fanno 2704 euro. Molto meglio che investirli in qualche fondo o altro.
 
Come si fa a copiare tutte le strategie di Buffet passo x passo?

Certe volte il caso....ho ritrovato questo documento nel quale una ricerca ha evidenziato quanto segue, spero sia chiaro;)
gioia23

Study by Professors Gerald Martin & John Puthenpurackal

Paper published Oct., 2007

Buy/Sell all BRK stocks on last day of month in which it is first made public that Berkshire bought or sold.

Period Berkshire BRK Stocks S&P 500
76 – 06 26.3% 25.0% 10.3%
97 – 06 12.5% 8.1% 6.7%
02 – 06 8.3% 15.0% 4.3%

Conclusion: BRK Stocks likely to beat S&P and possibly BRK.
 
Beh occorre considerare anche.... il cambio.
 
Mi sembra evidente che in caso di mercati negativi convenga comprare direttamente Brk, mentre sei mercati sono in trend positivo ('02-06) si può semplicemente andare a ruota.
 
dal WSJ del 17/4

visto che si guarda agli USA come esempio e soprattutto il nuovo governo e molto pro-usa, speriamo che imparino e mi chiedo se avessimo noi in Italia una magistratura del genere i nostri politici che farebbero???

Spitzerism Lives
April 17, 2008; Page A18
Eliot Spitzer is no longer on the prosecuting side of the criminal justice system. But his brand of extrajudicial punishment is alive and well among U.S. Attorneys. Take the case of former Gen Re CEO Joseph Brandon, who was forced to resign on Monday although he has not been charged with any crime and was by all accounts a superb manager.

Without insisting on any grant of immunity, Mr. Brandon cooperated in an investigation of a fraudulent reinsurance transaction between Gen Re and AIG. That investigation resulted in the convictions of one AIG employee and six Gen Re executives. Prosecutors wanted to make it seven and named Mr. Brandon an unindicted co-conspirator. But instead of charging Mr. Brandon and having to convince a jury of his guilt, they made it clear to Warren Buffett, Chairman of Gen Re parent Berkshire Hathaway, that Mr. Brandon had to go, according to various media reports.


Mr. Buffett didn't respond to our call for comment, although news accounts duly note that he never hired Mr. Brandon and simply inherited him when he bought the company. Not so long ago, however, Mr. Buffett was full of praise for his manager.

In his annual letter to shareholders two months ago, Mr. Buffett gushed, "Now, thanks to Joe Brandon . . . the luster of the company has been restored." Mr. Buffett went on to say that Mr. Brandon and President Tad Montross "have been running the business for six years and have been doing first-class business in a first-class way, to use the words of J. P. Morgan." Sounds like Mr. Brandon deserved a raise, not a dismissal.

We're tempted to conclude that we wouldn't want to be in a foxhole with Mr. Buffett, even a "first-class" foxhole. But the sad truth is that the Sage of Omaha may not have had much choice. Fiduciary duty to Berkshire shareholders requires him to avoid a criminal indictment of Gen Re at any cost. Such a reputational blow is a likely death sentence for any financial company.

The Justice Department's 2006 McNulty Memo put modest limits on prosecutors' ability to extort settlements from corporations. But U.S. Attorneys still have a free hand to pressure companies to fire people as a show of cooperation. Georgetown business professor John Hasnas says prosecutors rarely if ever tell corporations to fire their target, although Mr. Spitzer was an exception. But all they have to do is to suggest that they are considering whether to indict the corporation, and that the extent of their cooperation will be considered in the decision, and "the message gets across."

So we have the spectacle of Nora Dannehy, less than two weeks into the job of Acting U.S. Attorney for the District of Connecticut, essentially deciding that she has the right to punish a man she wasn't able to make a formal case against. Even if you're never charged, much less convicted, prosecutors can still take away your livelihood.

There's also the not so small matter that firing Mr. Brandon may harm Berkshire Hathaway shareholders. Mr. Spitzer forced the dismissal of both Hank Greenberg at AIG and Jeffrey Greenberg at Marsh & McLennan. Both companies have since seen their businesses decline and their share prices plummet. We have come to a strange pass in this country when prosecutors who can't prove their case can nonetheless tell Warren Buffett who can run his companies.
 
Attenzione che esiste anche la Berkshire B che costa circa 4300 dollari che al cambio attuale fanno 2704 euro. Molto meglio che investirli in qualche fondo o altro.

Sono diversi anni che ai clienti compro Berkshire per la parte azionaria americana, al posto dei soliti fondi e non mi sono mai pentito, anche se è la classica azione da lungo periodo_OK!
 
L'ultimo colpo di Warren:

Munich Re confirms Warren Buffett holds stake
April 17, 2008: 07:14 AM EST


FRANKFURT, Apr. 17, 2008 (Thomson Financial delivered by Newstex) -- Muenchener Rueckversicherungs AG. confirmed that U.S. investor Warren Buffett holds a stake in the German reinsurer via his firm Berkshire Hathaway Inc. (OOTC:HWYI) (NYSE:BRK A)

Munich Re expects Berkshire Hathaway to remain as an investor, chief executive Nikolaus von Bomhard said at the annual general meeting.

He did not disclose how large Buffett's stake is but welcomed the investment.

Last week, Frankfurter Allgemeine Zeitung reported that Buffett had acquired more than 1 million shares or at least 0.5 percent in Munich Re.

The report, which cited industry sources, said Buffett is considered a long-term investor but added that it is not certain if he continues to hold the Munich Re shares.

Copyright Thomson Financial News Limited 2008. All rights reserved.
 
Buffett e Moratti :eek::D
verrà in Europa e passerà anche da Milano in maggio,
visto che è giotto chissà che non si compri un pò di nutella;)
adesso abbiamo anche capito dove Moratti ha messo i soldi dopo
aver IPOizzato Saras ai piccoli:rolleyes:
avrà comprato Berkshire:D
gioia23


Buffett, Seeking Acquisitions, to Meet European `Dynasties'
By Josh P. Hamilton
April 22 (Bloomberg) -- Billionaire investor Warren Buffett
will visit Europe next month to scout potential acquisitions,
said an Italian organizer of the tour.
``The purpose of the trip is to meet family-owned companies,
owners of family companies, the typical European dynasties,''
said Angelo Moratti, vice president of Italian refiner Saras SpA,
in a telephone interview. ``His idea is that sooner or later one
of these great businesses will fall into his hands.''
Scheduled for the third week of May, the tour will take the
Berkshire Hathaway Inc. chairman to Milan, Madrid and as yet
undetermined cities in Germany and Switzerland, Moratti said.
Buffett, 77, has been looking outside the U.S. to put his
company's more than $40 billion in cash to work. Moratti said he
is organizing the tour along with Eitan Wertheimer, president of
Israel-based Iscar Metalworking Cos., acquired by Berkshire in
2006 in Buffett's first non-U.S. acquisition.
Buffett didn't immediately respond to a request for comment
through his spokeswoman, Jackie Wilson. Wertheimer didn't
immediately respond to an e-mailed request to his assistant,
Dalia Seatter.
``There's a lot of interest'' in meeting with Buffett, said
Moratti, who helps run the energy company his grandfather founded
more than 40 years ago. Saras, which owns the Mediterranean
region's largest oil refinery, went public in 2006.
Moratti said he's been a student of Buffett's investing
style and a Berkshire investor for more than 10 years. He said he
met Buffett about eight years ago through Berkshire's NetJets, a
fractional jet ownership company.
Buffett built Omaha, Nebraska-based Berkshire over four
decades from a failing textile maker into a $200 billion holding
company with businesses ranging from candy making to insurance.
Buffett is the world's richest person, according to Forbes
magazine.
 
Indietro